Development of NFkappaB Inhibitors
Small Business Information
ATHERSYS, INC., 3201 CARNEGIE AVE, CLEVELAND, OH, 44115
AbstractDESCRIPTION (provided by applicant): The goal of this Phase I proposal is to identify novel regulators of transcription factor NFkappaB. The products of this Phase I discovery program will be targets utilized in a Phase II campaign to develop of small mol
* information listed above is at the time of submission.